Flu vaccine lots that have been released by FDA and are available for distribution by manufacturer:

Sanofi Pasteur Inc
Discovery Drive
Swiftwater, PA 18370
License 1725
Fluzone - 2 

FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) met in Gaithersburg, Maryland, on February 21, 2008, to select the influenza virus strains for the composition of the influenza vaccine for use in the 2008-2009 U.S. influenza season. During this meeting, the advisory panel reviewed and evaluated the surveillance data related to epidemiology and antigenic characteristics, serological responses to 2007/2008 vaccines, and the availability of candidate strains and reagents.

The panel recommended that vaccines to be used in the 2008-2009 influenza season in the U.S. contain the following:

   1. An  A/Brisbane/59/2007 (H1N1)-like virus 
   2. An  A/Brisbane/10/2007 (H3N2)-like virus {A/Brisbane/10/2007 is a current southern hemisphere vaccine virus} 
   3. A  B/Florida/4/2006-like virus {B/Florida/4/2006 and B/Brisbane/3/2007 (a B/Florida/4/2006-like virus) are current southern hemisphere vaccine viruses} 

The influenza vaccine composition to be used in the 2008-2009 influenza season in the U.S. is identical to that recommended by the World Health Organization on February 14, 2008, for the Northern Hemisphere's 2008-2009 influenza season.

Anticipated product availability for the 2008-2009 season:
*Influenza Virus Vaccine (FluLaval)
*Influenza Virus Vaccine Live, Intranasal (FluMist) *Influenza Virus Vaccine (Fluzone) 


Zynchros Pharmacy Services